Elevated interleukin-6 and adverse outcomes in COVID-19 patients: a meta-analysis based on adjusted effect estimates

被引:9
作者
Zhang, Peihua [1 ]
Shi, Li [1 ]
Xu, Jie [1 ]
Wang, Yadong [2 ]
Yang, Haiyan [1 ]
机构
[1] Zhengzhou Univ, Dept Epidemiol, Coll Publ Hlth, Zhengzhou 450001, Peoples R China
[2] Henan Ctr Dis Control & Prevent, Dept Toxicol, Zhengzhou 450016, Peoples R China
基金
中国国家自然科学基金;
关键词
COVID-19; IL-6; Adverse outcomes; Meta-analysis; Adjusted effect estimates; SEVERITY;
D O I
10.1007/s00251-020-01179-1
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
This study aimed to evaluate the association of interleukin-6 (IL-6) level with the poor outcomes in coronavirus disease 2019 (COVID-19) patients by utilizing a meta-analysis based on adjusted effect estimates. We searched the keywords from PubMed, Web of Science, and EMBASE on August 14, 2020. The pooled effects and 95% confidence interval (95% CI) were estimated by Stata 11.2. Subgroup analysis and meta-regression were performed to explore the source of heterogeneity. Sensitivity analysis was implemented to assess the stability of the results. Begg's test and Egger's test were conducted to assess the publication bias. Sixteen articles with 8752 COVID-19 patients were finally included in the meta-analysis. The results based on random-effects model indicated that elevated value of IL-6 was significantly associated with adverse outcomes in patients with COVID-19 (pooled effect = 1.21, 95% CI 1.13-1.31,I-2 = 90.7%). Subgroup analysis stratified by disease outcomes showed consistent results (severe: pooled effect = 1.18, 95% CI 1.05-1.31; ICU (intensive care unit) admission: pooled effect = 1.90, 95% CI 1.04-3.47; death: pooled effect = 3.57, 95% CI 2.10-6.07). Meta-regression indicated that study design was a source of heterogeneity. Publication bias was existent in our analysis (Begg's test:P = 0.007; Egger's test:P < 0.001). In conclusion, the elevated IL-6 level is an independent risk factor associated with adverse outcomes in patients with COVID-19.
引用
收藏
页码:431 / 437
页数:7
相关论文
共 19 条
[1]  
AYANIAN S, 2020, BIOMARK MED
[2]   Prevalence and Predictive Value of Anemia and Dysregulated Iron Homeostasis in Patients with COVID-19 Infection [J].
Bellmann-Weiler, Rosa ;
Lanser, Lukas ;
Barket, Robert ;
Rangger, Lukas ;
Schapfl, Anna ;
Schaber, Marc ;
Fritsche, Gernot ;
Woell, Ewald ;
Weiss, Guenter .
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) :1-11
[3]   COVID-19 in a designated infectious diseases hospital outside Hubei Province, China [J].
Cai, Qingxian ;
Huang, Deliang ;
Ou, Pengcheng ;
Yu, Hong ;
Zhu, Zhibin ;
Xia, Zhang ;
Su, Yinan ;
Ma, Zhenghua ;
Zhang, Yiming ;
Li, Zhiwei ;
He, Qing ;
Liu, Lei ;
Fu, Yang ;
Chen, Jun .
ALLERGY, 2020, 75 (07) :1742-1752
[4]  
Cummings Matthew J, 2020, Lancet, V395, P1763, DOI [10.1101/2020.04.15.20067157, 10.1016/S0140-6736(20)31189-2]
[5]  
Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1038/s41591-020-1051-9, 10.1101/2020.05.28.20115758]
[6]   Clinical characteristics of 312 hospitalized older patients with COVID-19 in Wuhan, China [J].
Li, Tao ;
Lu, Lei ;
Zhang, Weishuo ;
Tao, Yu ;
Wang, Liuming ;
Bao, Jing ;
Liu, Bao ;
Duan, Jun .
ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2020, 91
[7]   Alteration of serum markers in COVID-19 and implications on mortality [J].
Liu, Dan ;
Li, Ruyuan ;
Yu, Ruidi ;
Wang, Ya ;
Feng, Xinxia ;
Yuan, Yuan ;
Wang, Siyuan ;
Zeng, Shaoqing ;
Gao, Yue ;
Xu, Sen ;
Li, Huayi ;
Jiao, Xiaofei ;
Chi, Jianhua ;
Yu, Yang ;
Song, Chunyan ;
Jin, Ning ;
Cui, Pengfei ;
Liu, Jiahao ;
Zheng, Xu ;
Gong, Wenjian ;
Liu, Xingyu ;
Cai, Guangyao ;
Song, Jianming ;
Kwan, Susan Yuk-Lin ;
Desai, Aakash ;
Li, Chunrui ;
Gao, Qinglei .
CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 10 (03)
[8]   Prevalence and predictive value of hypocalcemia in severe COVID-19 patients [J].
Liu, Jingmei ;
Han, Ping ;
Wu, Jingwen ;
Gong, Jin ;
Tian, Dean .
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2020, 13 (09) :1224-1228
[9]   Hyperglycemia is a strong predictor of poor prognosis in COVID-19 [J].
Liu, Sheng-ping ;
Zhang, Qin ;
Wang, Wei ;
Zhang, Min ;
Liu, Chun ;
Xiao, Xuefei ;
Liu, Zongdao ;
Hu, Wen-mu ;
Jin, Ping .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 167
[10]   Dynamic Interleukin-6 Level Changes as a Prognostic Indicator in Patients With COVID-19 [J].
Liu, Zeming ;
Li, Jinpeng ;
Chen, Danyang ;
Gao, Rongfen ;
Zeng, Wen ;
Chen, Sichao ;
Huang, Yihui ;
Huang, Jianglong ;
Long, Wei ;
Li, Man ;
Guo, Liang ;
Wang, Xinghuan ;
Wu, Xiaohui .
FRONTIERS IN PHARMACOLOGY, 2020, 11